Published in J Clin Oncol on November 10, 2007
Tablet-based Patient Reported Outcome | NCT01991691
Work Ability in Young Adult Survivors (WAYS) | NCT03148080
Acupressure for Children in Treatment for a Childhood Cancer (ACT-CC) | NCT03313193
The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008. J Clin Epidemiol (2010) 10.65
Quality of life after allogeneic hematopoietic cell transplantation. Blood (2009) 2.49
The development of a clinical outcomes survey research application: Assessment Center. Qual Life Res (2010) 2.37
Minimally important differences were estimated for six Patient-Reported Outcomes Measurement Information System-Cancer scales in advanced-stage cancer patients. J Clin Epidemiol (2011) 2.24
Effect of ruxolitinib therapy on myelofibrosis-related symptoms and other patient-reported outcomes in COMFORT-I: a randomized, double-blind, placebo-controlled trial. J Clin Oncol (2013) 1.70
How item banks and their application can influence measurement practice in rehabilitation medicine: a PROMIS fatigue item bank example. Arch Phys Med Rehabil (2011) 1.64
The 2009-2013 research agenda for oncology nursing. Oncol Nurs Forum (2009) 1.57
Focus article: report of the NIH Task Force on Research Standards for Chronic Low Back Pain. Eur Spine J (2014) 1.51
Using cognitive interviews to evaluate items for measuring sexual functioning across cancer populations: improvements and remaining challenges. Qual Life Res (2009) 1.46
Quality of life supersedes the classic prognosticators for long-term survival in locally advanced non-small-cell lung cancer: an analysis of RTOG 9801. J Clin Oncol (2009) 1.34
Patient-reported outcomes of cancer survivors in England 1-5 years after diagnosis: a cross-sectional survey. BMJ Open (2013) 1.33
Effects of a problem-solving intervention (COPE) on quality of life for patients with advanced cancer on clinical trials and their caregivers: simultaneous care educational intervention (SCEI): linking palliation and clinical trials. J Palliat Med (2011) 1.24
ASCPRO recommendations for the assessment of fatigue as an outcome in clinical trials. J Pain Symptom Manage (2010) 1.23
The PROMIS initiative: involvement of rehabilitation stakeholders in development and examples of applications in rehabilitation research. Arch Phys Med Rehabil (2011) 1.21
Measuring social health in the patient-reported outcomes measurement information system (PROMIS): item bank development and testing. Qual Life Res (2010) 1.17
Correlates and outcomes of fatigue among incident dialysis patients. Clin J Am Soc Nephrol (2009) 1.13
Recommendations for high-priority research on cancer-related fatigue in children and adults. J Natl Cancer Inst (2013) 1.11
The problem with health measurement. Patient Prefer Adherence (2011) 1.10
Management of gastrointestinal symptoms in advanced cancer patients: the rapid learning cancer clinic model. Curr Opin Support Palliat Care (2010) 1.08
Patient-reported outcome measures in inflammatory bowel disease. Can J Gastroenterol Hepatol (2014) 1.07
Methodological issues regarding power of classical test theory (CTT) and item response theory (IRT)-based approaches for the comparison of patient-reported outcomes in two groups of patients--a simulation study. BMC Med Res Methodol (2010) 1.06
Qualitative analysis of patients' feedback from a PROMs survey of cancer patients in England. BMJ Open (2013) 1.04
Comparison of numerical and verbal rating scales to measure pain exacerbations in patients with chronic cancer pain. Health Qual Life Outcomes (2010) 1.03
Do high symptom scores trigger clinical actions? An audit after implementing electronic symptom screening. J Oncol Pract (2012) 1.01
A systematic review of head and neck cancer quality of life assessment instruments. Oral Oncol (2012) 0.99
Report of the NIH Task Force on research standards for chronic low back pain. J Pain (2014) 0.98
Auricular point acupressure to manage chronic low back pain in older adults: a randomized controlled pilot study. Evid Based Complement Alternat Med (2014) 0.95
Environmental factors item development for persons with stroke, traumatic brain injury, and spinal cord injury. Arch Phys Med Rehabil (2013) 0.94
Prospective assessment of chemotherapy-induced peripheral neuropathy due to weekly paclitaxel in patients with advanced or metastatic breast cancer (CSP-HOR 02 study). Support Care Cancer (2008) 0.93
Sexuality after hematopoietic stem cell transplantation. Cancer J (2009) 0.93
Yoga & cancer interventions: a review of the clinical significance of patient reported outcomes for cancer survivors. Evid Based Complement Alternat Med (2012) 0.93
Resilience, health, and quality of life among long-term survivors of hematopoietic cell transplantation. Cancer (2015) 0.93
The EORTC emotional functioning computerized adaptive test: phases I-III of a cross-cultural item bank development. Psychooncology (2013) 0.92
The king's foot of patient-reported outcomes: current practices and new developments for the measurement of change. Qual Life Res (2011) 0.92
The metabolic syndrome and mind-body therapies: a systematic review. J Nutr Metab (2011) 0.90
Development of items designed to evaluate activity performance and participation in children and adolescents with spinal cord injury. Int J Pediatr (2009) 0.90
Patient-Reported Outcomes vs. Clinician Symptom Reporting During Chemoradiation for Rectal Cancer. Gastrointest Cancer Res (2012) 0.89
Needs of older caregivers of patients with advanced cancer. J Am Geriatr Soc (2009) 0.87
Report of the NIH Task Force on research standards for chronic low back pain. Phys Ther (2015) 0.87
The Adverse Effect of Weight Stigma on the Well-Being of Medical Students with Overweight or Obesity: Findings from a National Survey. J Gen Intern Med (2015) 0.86
Distress among young adult cancer survivors: a cohort study. Support Care Cancer (2013) 0.84
Cancer screening and genetics: a tale of two paradigms. Cancer Epidemiol Biomarkers Prev (2014) 0.84
Obesity is associated with worse quality of life in women with gynecologic malignancies: an opportunity to improve patient-centered outcomes. Cancer (2014) 0.82
The BraveNet prospective observational study on integrative medicine treatment approaches for pain. BMC Complement Altern Med (2013) 0.82
PROMIS for Laparoscopy. J Gastrointest Surg (2015) 0.81
Lifting symptom burden--how far off the ground are we? Support Care Cancer (2008) 0.81
Ultra-mini PCNL versus flexible ureteroscopy: a matched analysis of analgesic consumption and treatment-related patient satisfaction in patients with renal stones 10-35 mm. World J Urol (2015) 0.80
Fatigue in Patients with Chronic Hepatitis B Living in North America: Results from the Hepatitis B Research Network (HBRN). Dig Dis Sci (2016) 0.80
Mental health outcomes during colorectal cancer survivorship: a review of the literature. Psychooncology (2015) 0.79
Can we agree on patient-reported outcome measures for assessing hematopoietic cell transplantation patients? A study from the CIBMTR and BMT CTN. Bone Marrow Transplant (2016) 0.79
The nature of life-transforming changes among cancer survivors. Qual Health Res (2013) 0.79
Development of a fatigue and functional impact scale in anemic cancer patients receiving chemotherapy. Cancer (2008) 0.78
Report of the NIH Task Force on Research Standards for Chronic Low Back Pain. Int J Ther Massage Bodywork (2015) 0.77
Pain and emotional distress among substance-use patients beginning treatment relative to a representative comparison group. J Addict Med (2014) 0.77
Tai chi mind-body exercise in patients with COPD: study protocol for a randomized controlled trial. Trials (2014) 0.77
Pharmaceutical care for patients with breast and ovarian cancer. Support Care Cancer (2012) 0.76
Characterizing Fatigue: The Effects of Ethnicity and Acculturation. J Appl Biobehav Res (2012) 0.76
Evaluation of the psychometric properties of the PROMIS Cancer Fatigue Short Form with cancer patients. J Psychosom Res (2015) 0.76
Validity assessment of the PROMIS fatigue domain among people living with HIV. AIDS Res Ther (2017) 0.75
Assessment of patient-reported outcome measures in the surgical treatment of patients with gastric cancer. Surg Endosc (2015) 0.75
The challenges of cancer pain assessment. Ulster Med J (2014) 0.75
Longitudinal patterns of cancer patient reported outcomes in end of life care predict survival. Support Care Cancer (2015) 0.75
Quality of Life in Children With Advanced Cancer: A Report From the PediQUEST Study. J Pain Symptom Manage (2016) 0.75
Detecting When "Quality of Life" Has Been "Enhanced": Estimating Change in Quality of Life Ratings. Open J Philos (2013) 0.75
Symptom experiences in metastatic breast cancer patients: relationships to activity engagement, value-based living, and psychological inflexibility. Psychooncology (2016) 0.75
The challenge of measuring intra-individual change in fatigue during cancer treatment. Qual Life Res (2016) 0.75
Persistent Fatigue in Hematopoietic Stem Cell Transplantation Survivors. Cancer Nurs (2016) 0.75
Assessment of patient-reported outcomes in patients with melanoma. Surg Oncol Clin N Am (2011) 0.75
Varying the item format improved the range of measurement in patient-reported outcome measures assessing physical function. Arthritis Res Ther (2017) 0.75
Rethinking fatigue in Gaucher disease. Orphanet J Rare Dis (2016) 0.75
Experiences of healing therapy in patients with irritable bowel syndrome and inflammatory bowel disease. BMC Complement Altern Med (2015) 0.75
Managing Patients With Myelofibrosis in the Era of Janus Kinase Inhibitors. J Adv Pract Oncol (2015) 0.75
A pilot study of patient-centered outcome assessment using PROMIS for patients undergoing colorectal surgery. Support Care Cancer (2017) 0.75
Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer. N Engl J Med (2007) 20.19
Ecological momentary assessment. Annu Rev Clin Psychol (2008) 13.68
Psychometric evaluation and calibration of health-related quality of life item banks: plans for the Patient-Reported Outcomes Measurement Information System (PROMIS). Med Care (2007) 12.71
Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial. Lancet (2011) 12.13
Pazopanib versus sunitinib in metastatic renal-cell carcinoma. N Engl J Med (2013) 10.74
The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008. J Clin Epidemiol (2010) 10.65
Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain (2007) 8.89
Evaluation of item candidates: the PROMIS qualitative item review. Med Care (2007) 8.77
A survey method for characterizing daily life experience: the day reconstruction method. Science (2004) 7.37
Effects of Testosterone Treatment in Older Men. N Engl J Med (2016) 6.66
Randomized, controlled, double-blind, cross-over trial assessing treatment preference for pazopanib versus sunitinib in patients with metastatic renal cell carcinoma: PISCES Study. J Clin Oncol (2014) 6.64
Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol (2007) 6.24
Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer. JAMA (2012) 5.90
Measuring spiritual well-being in people with cancer: the functional assessment of chronic illness therapy--Spiritual Well-being Scale (FACIT-Sp). Ann Behav Med (2002) 5.69
The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation. Health Qual Life Outcomes (2003) 5.58
Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial. J Clin Oncol (2011) 5.43
Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. J Clin Oncol (2002) 4.69
Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet (2006) 4.26
Item banks for measuring emotional distress from the Patient-Reported Outcomes Measurement Information System (PROMIS®): depression, anxiety, and anger. Assessment (2011) 4.21
Representativeness of the Patient-Reported Outcomes Measurement Information System Internet panel. J Clin Epidemiol (2010) 4.18
Measuring health-related quality of life in patients with hepatobiliary cancers: the functional assessment of cancer therapy-hepatobiliary questionnaire. J Clin Oncol (2002) 4.16
Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items. Qual Life Res (2009) 4.13
The future of outcomes measurement: item banking, tailored short-forms, and computerized adaptive assessment. Qual Life Res (2007) 4.01
Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol (2004) 3.85
Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force report. Value Health (2008) 3.68
Assessment of pain: a community-based diary survey in the USA. Lancet (2008) 3.67
Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer. Health Qual Life Outcomes (2007) 3.66
Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancer. J Clin Oncol (2012) 3.65
Randomized phase II trial of sunitinib on an intermittent versus continuous dosing schedule as first-line therapy for advanced renal cell carcinoma. J Clin Oncol (2012) 3.65
Randomized phase II trial of first-line treatment with sorafenib versus interferon Alfa-2a in patients with metastatic renal cell carcinoma. J Clin Oncol (2009) 3.65
Would you be happier if you were richer? A focusing illusion. Science (2006) 3.62
Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol (2004) 3.57
Tivozanib versus sorafenib as initial targeted therapy for patients with metastatic renal cell carcinoma: results from a phase III trial. J Clin Oncol (2013) 3.48
A comprehensive method for the translation and cross-cultural validation of health status questionnaires. Eval Health Prof (2005) 3.43
Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales. J Pain Symptom Manage (2002) 3.35
Fatigue in cancer patients compared with fatigue in the general United States population. Cancer (2002) 3.34
Assessment of neurological and behavioural function: the NIH Toolbox. Lancet Neurol (2010) 3.20
Applying item response theory (IRT) modeling to questionnaire development, evaluation, and refinement. Qual Life Res (2007) 3.10
Item response theory analyses of physical functioning items in the medical outcomes study. Med Care (2007) 3.10
Clinical significance of patient-reported questionnaire data: another step toward consensus. J Clin Epidemiol (2005) 2.98
Evaluation of the Healthy Eating Index-2005. J Am Diet Assoc (2008) 2.93
Development of a PROMIS item bank to measure pain interference. Pain (2010) 2.85
Influence of pre- and postdiagnosis physical activity on mortality in breast cancer survivors: the health, eating, activity, and lifestyle study. J Clin Oncol (2008) 2.85
Recommendations for incorporating patient-reported outcomes into clinical comparative effectiveness research in adult oncology. J Clin Oncol (2012) 2.82
Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study. J Clin Oncol (2009) 2.82
Developing tailored instruments: item banking and computerized adaptive assessment. Qual Life Res (2007) 2.76
Initial validation of a self-report measure of the extent of and reasons for medication nonadherence. Med Care (2012) 2.70
Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial. Lancet Oncol (2012) 2.65
The accuracy of pain and fatigue items across different reporting periods. Pain (2008) 2.57
Patient self-reports of symptoms and clinician ratings as predictors of overall cancer survival. J Natl Cancer Inst (2011) 2.56
Efficiency of static and computer adaptive short forms compared to full-length measures of depressive symptoms. Qual Life Res (2009) 2.55
Quality of life following localized prostate cancer treated initially with androgen deprivation therapy or no therapy. J Natl Cancer Inst (2002) 2.54
General population and cancer patient norms for the Functional Assessment of Cancer Therapy-General (FACT-G). Eval Health Prof (2005) 2.51
Responsiveness and minimal important differences for patient reported outcomes. Health Qual Life Outcomes (2006) 2.48
Identifying important outcome domains for chronic pain clinical trials: an IMMPACT survey of people with pain. Pain (2007) 2.47
Implementing patient-reported outcomes assessment in clinical practice: a review of the options and considerations. Qual Life Res (2011) 2.42
Randomized, controlled trial of an easy-to-read informed consent statement for clinical trial participation: a study of the Eastern Cooperative Oncology Group. J Clin Oncol (2003) 2.41
Progress in assessing physical function in arthritis: PROMIS short forms and computerized adaptive testing. J Rheumatol (2009) 2.39
PROMIS Pediatric Pain Interference Scale: an item response theory analysis of the pediatric pain item bank. J Pain (2010) 2.38
Treatment-emergent endocrine symptoms and the risk of breast cancer recurrence: a retrospective analysis of the ATAC trial. Lancet Oncol (2008) 2.34
Item banking to improve, shorten and computerize self-reported fatigue: an illustration of steps to create a core item bank from the FACIT-Fatigue Scale. Qual Life Res (2003) 2.32
Are inflammatory cytokines the common link between cancer-associated cachexia and depression? J Support Oncol (2005) 2.27
Associations of insulin resistance and adiponectin with mortality in women with breast cancer. J Clin Oncol (2010) 2.26
An item response analysis of the pediatric PROMIS anxiety and depressive symptoms scales. Qual Life Res (2010) 2.25
Minimally important differences were estimated for six Patient-Reported Outcomes Measurement Information System-Cancer scales in advanced-stage cancer patients. J Clin Epidemiol (2011) 2.24
Evaluating equivalency between response systems: application of the Rasch model to a 3-level and 5-level EQ-5D. Med Care (2007) 2.22
Cancer, comorbidities, and health-related quality of life of older adults. Health Care Financ Rev (2008) 2.20
Impact of cancer on health-related quality of life of older Americans. J Natl Cancer Inst (2009) 2.20
Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial. J Natl Cancer Inst (2002) 2.19
Relative to the general US population, chronic diseases are associated with poorer health-related quality of life as measured by the Patient-Reported Outcomes Measurement Information System (PROMIS). J Clin Epidemiol (2010) 2.19
Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy. Cancer (2002) 2.17
Assessment of quality of cancer-related follow-up care from the cancer survivor's perspective. J Clin Oncol (2011) 2.16
Construction of the eight-item patient-reported outcomes measurement information system pediatric physical function scales: built using item response theory. J Clin Epidemiol (2011) 2.16
Introduction: Understanding and influencing multilevel factors across the cancer care continuum. J Natl Cancer Inst Monogr (2012) 2.15
A combination of distribution- and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scale. J Clin Epidemiol (2004) 2.14
Predicting EuroQol (EQ-5D) scores from the patient-reported outcomes measurement information system (PROMIS) global items and domain item banks in a United States sample. Qual Life Res (2009) 2.10
Quality of life of patients with endometrial cancer undergoing laparoscopic international federation of gynecology and obstetrics staging compared with laparotomy: a Gynecologic Oncology Group study. J Clin Oncol (2009) 2.08
What is sufficient evidence for the reliability and validity of patient-reported outcome measures? Value Health (2007) 2.06
Neuro-QOL: quality of life item banks for adults with neurological disorders: item development and calibrations based upon clinical and general population testing. Qual Life Res (2011) 1.97
Understanding high-quality cancer care: a summary of expert perspectives. Cancer (2008) 1.97
ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research. Qual Life Res (2013) 1.96
Quality of life of postmenopausal women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) Adjuvant Breast Cancer Trial. J Clin Oncol (2004) 1.95
Symptoms and treatment burden associated with cancer treatment: results from a cross-sectional national survey in the U.S. Support Care Cancer (2008) 1.89
Health-related quality of life during and after intraperitoneal versus intravenous chemotherapy for optimally debulked ovarian cancer: a Gynecologic Oncology Group Study. J Clin Oncol (2007) 1.88
Issues in the development of an item bank. Arch Phys Med Rehabil (2003) 1.87
The use of PROMIS and assessment center to deliver patient-reported outcome measures in clinical research. J Appl Meas (2010) 1.87
Psychometric comparison of the standard EQ-5D to a 5 level version in cancer patients. Med Care (2007) 1.87
Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations. Pain (2010) 1.84
Possible socioeconomic and ethnic disparities in quality of life in a cohort of breast cancer survivors. Breast Cancer Res Treat (2007) 1.84
The use of patient-reported outcomes (PRO) within comparative effectiveness research: implications for clinical practice and health care policy. Med Care (2012) 1.84
Patient-reported outcomes assessment in cancer trials: taking stock, moving forward. J Clin Oncol (2007) 1.84